Atlas FDA

Coaptite

FDA premarket approval P040047/S052 · decided 2019-06-26

Approval details

PMA number
P040047
Supplement
S052
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Coaptite
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Merz North America, Inc.
Date received
2019-01-07
Decision date
2019-06-26
Days to decision
170 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Franksville, WI
Statement
Approval for a Post-Approval Study Labeling update.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29